Spectral Medical Inc. (OTCMKTS:EDTXF) Short Interest Update

Spectral Medical Inc. (OTCMKTS:EDTXF) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 77,100 shares, an increase of 7.2% from the May 15th total of 71,900 shares. Based on an average daily trading volume, of 29,100 shares, the short-interest ratio is currently 2.6 days.

Spectral Medical Price Performance

Spectral Medical stock opened at $0.36 on Wednesday. The company’s 50-day moving average price is $0.35 and its 200-day moving average price is $0.36. Spectral Medical has a twelve month low of $0.18 and a twelve month high of $0.50. The company has a market cap of $100.63 million, a PE ratio of -7.20 and a beta of 0.89.

Spectral Medical (OTCMKTS:EDTXF) last posted its earnings results on Monday, May 13th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.50 million for the quarter.

Spectral Medical Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.